Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow SNMMI on Twitter
  • Visit SNMMI on Facebook
Research ArticleTheranostics

68Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer

Clemens Kratochwil, Paul Flechsig, Thomas Lindner, Labidi Abderrahim, Annette Altmann, Walter Mier, Sebastian Adeberg, Hendrik Rathke, Manuel Röhrich, Hauke Winter, Peter K. Plinkert, Frederik Marme, Matthias Lang, Hans-Ulrich Kauczor, Dirk Jäger, Jürgen Debus, Uwe Haberkorn and Frederik L. Giesel
Journal of Nuclear Medicine June 2019, 60 (6) 801-805; DOI: https://doi.org/10.2967/jnumed.119.227967
Clemens Kratochwil
1Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Flechsig
1Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany
2Translational Lung Research Center Heidelberg, German Center for Lung Research, Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Lindner
1Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Labidi Abderrahim
1Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Annette Altmann
1Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany
3Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Walter Mier
1Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sebastian Adeberg
4Department of Radiation Oncology, University Hospital Heidelberg, Heidelberg, Germany
5Heidelberg Institute for Radiation Oncology, Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hendrik Rathke
1Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manuel Röhrich
1Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hauke Winter
2Translational Lung Research Center Heidelberg, German Center for Lung Research, Heidelberg, Germany
6Department of Surgery, Thoraxklinik at University Hospital Heidelberg, Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter K. Plinkert
7Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Heidelberg, Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frederik Marme
8Department Obstetrics and Gynecology, University Hospital Heidelberg, Heidelberg, Germany
9Department Obstetrics and Gynecology, University Hospital Mannheim, Mannheim, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthias Lang
10Department of Surgery, University Hospital Heidelberg, Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hans-Ulrich Kauczor
2Translational Lung Research Center Heidelberg, German Center for Lung Research, Heidelberg, Germany
11Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dirk Jäger
12Department of Medical Oncology and Internal Medicine VI, National Center for Tumor Diseases, University Hospital Heidelberg, Germany
13Clinical Cooperation Unit Applied Tumor Immunity, German Cancer Research Center, Heidelberg, Germany; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jürgen Debus
4Department of Radiation Oncology, University Hospital Heidelberg, Heidelberg, Germany
5Heidelberg Institute for Radiation Oncology, Heidelberg, Germany
14Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center, Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Uwe Haberkorn
1Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany
2Translational Lung Research Center Heidelberg, German Center for Lung Research, Heidelberg, Germany
3Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frederik L. Giesel
1Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 60 no. 6 801-805
DOI 
https://doi.org/10.2967/jnumed.119.227967
PubMed 
30954939

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication March 5, 2019
  • Accepted for publication March 19, 2019
  • Published online June 3, 2019.

Article Versions

  • previous version (April 6, 2019 - 09:28).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2019 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Clemens Kratochwil*,1,
  2. Paul Flechsig*,1,2,
  3. Thomas Lindner1,
  4. Labidi Abderrahim1,
  5. Annette Altmann1,3,
  6. Walter Mier1,
  7. Sebastian Adeberg4,5,
  8. Hendrik Rathke1,
  9. Manuel Röhrich1,
  10. Hauke Winter2,6,
  11. Peter K. Plinkert7,
  12. Frederik Marme8,9,
  13. Matthias Lang10,
  14. Hans-Ulrich Kauczor2,11,
  15. Dirk Jäger12,13,
  16. Jürgen Debus4,5,14,
  17. Uwe Haberkorn1–3 and
  18. Frederik L. Giesel1
  1. 1Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany
  2. 2Translational Lung Research Center Heidelberg, German Center for Lung Research, Heidelberg, Germany
  3. 3Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Heidelberg, Germany
  4. 4Department of Radiation Oncology, University Hospital Heidelberg, Heidelberg, Germany
  5. 5Heidelberg Institute for Radiation Oncology, Heidelberg, Germany
  6. 6Department of Surgery, Thoraxklinik at University Hospital Heidelberg, Heidelberg, Germany
  7. 7Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Heidelberg, Heidelberg, Germany
  8. 8Department Obstetrics and Gynecology, University Hospital Heidelberg, Heidelberg, Germany
  9. 9Department Obstetrics and Gynecology, University Hospital Mannheim, Mannheim, Germany
  10. 10Department of Surgery, University Hospital Heidelberg, Heidelberg, Germany
  11. 11Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, Heidelberg, Germany
  12. 12Department of Medical Oncology and Internal Medicine VI, National Center for Tumor Diseases, University Hospital Heidelberg, Germany
  13. 13Clinical Cooperation Unit Applied Tumor Immunity, German Cancer Research Center, Heidelberg, Germany; and
  14. 14Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center, Heidelberg, Germany
  1. For correspondence or reprints contact: Clemens Kratochwil, Department of Nuclear Medicine, University Hospital Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany. E-mail: clemens.kratochwil{at}med.uni-heidelberg.de
  1. ↵* Contributed equally to this work.

View Full Text

Cited By...

  • 117 Citations
  • Google Scholar

Article usage

Article usage: April 2019 to March 2021

AbstractFullPdf
Apr 20198560176
May 20193670102
Jun 20195294301736
Jul 20191479203248
Aug 2019777118134
Sep 2019762133120
Oct 2019762128157
Nov 2019596135151
Dec 2019438109176
Jan 2020578134164
Feb 2020434153222
Mar 2020439130136
Apr 2020329116154
May 2020345132181
Jun 2020335167211
Jul 202023891140
Aug 2020379153215
Sep 2020461137222
Oct 2020552173254
Nov 2020487151251
Dec 2020289213252
Jan 2021139574317
Feb 2021160568280
Mar 2021150595358
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 60 (6)
Journal of Nuclear Medicine
Vol. 60, Issue 6
June 1, 2019
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
68Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
68Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer
Clemens Kratochwil, Paul Flechsig, Thomas Lindner, Labidi Abderrahim, Annette Altmann, Walter Mier, Sebastian Adeberg, Hendrik Rathke, Manuel Röhrich, Hauke Winter, Peter K. Plinkert, Frederik Marme, Matthias Lang, Hans-Ulrich Kauczor, Dirk Jäger, Jürgen Debus, Uwe Haberkorn, Frederik L. Giesel
Journal of Nuclear Medicine Jun 2019, 60 (6) 801-805; DOI: 10.2967/jnumed.119.227967

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
68Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer
Clemens Kratochwil, Paul Flechsig, Thomas Lindner, Labidi Abderrahim, Annette Altmann, Walter Mier, Sebastian Adeberg, Hendrik Rathke, Manuel Röhrich, Hauke Winter, Peter K. Plinkert, Frederik Marme, Matthias Lang, Hans-Ulrich Kauczor, Dirk Jäger, Jürgen Debus, Uwe Haberkorn, Frederik L. Giesel
Journal of Nuclear Medicine Jun 2019, 60 (6) 801-805; DOI: 10.2967/jnumed.119.227967
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Mars Shot for Nuclear Medicine, Molecular Imaging, and Molecularly Targeted Radiopharmaceutical Therapy
  • Immunotherapy with immunocytokines and PD-1 blockade enhances the anticancer activity of small molecule-drug conjugates targeting carbonic anhydrase IX
  • Targeting Fibroblast Activation Protein: Radiosynthesis and Preclinical Evaluation of an 18F-Labeled FAP Inhibitor
  • The Future of Nuclear Medicine, Molecular Imaging, and Theranostics
  • Imaging the Cancer Immune Environment and Its Response to Pharmacologic Intervention, Part 2: The Role of Novel PET Agents
  • Design and Development of 99mTc-Labeled FAPI Tracers for SPECT Imaging and 188Re Therapy
  • Imaging Fibroblast Activation Protein Alpha Improves Diagnosis of Metastatic Prostate Cancer with Positron Emission Tomography
  • The Role of 68Ga-FAPI PET/CT for Patients with Malignancies of the Lower Gastrointestinal Tract: First Clinical Experience
  • Radiation Dosimetry and Biodistribution of 68Ga-FAPI-46 PET Imaging in Cancer Patients
  • The Future of Nuclear Medicine Depends on the Quality of Its Research: Researchers at the University of Heidelberg Receive the Award for Best Article of the Year
  • High-resolution positron emission microscopy of patient-derived tumor organoids
  • Reversibility of 68Ga-FAPI-2 Trapping Might Prove an Asset for PET Quantitative Imaging
  • Theranostics Targeting Fibroblast Activation Protein in the Tumor Stroma: 64Cu- and 225Ac-Labeled FAPI-04 in Pancreatic Cancer Xenograft Mouse Models
  • FAP: The Next Billion Dollar Nuclear Theranostics Target?
  • A Conversation Between Uwe Haberkorn and Johannes Czernin
  • Google Scholar

More in this TOC Section

Theranostics

  • Assessing Response to [177Lu]PSMA Radioligand Therapy using modified PSMA PET Progression Criteria
  • 177Lu-Labeled Albumin-Binder–Conjugated PSMA-Targeting Agents with Extremely High Tumor Uptake and Enhanced Tumor-to-Kidney Absorbed Dose Ratio
  • High Interobserver Agreement for the Standardized Reporting System SSTR-RADS 1.0 on Somatostatin Receptor PET/CT
Show more Theranostics

Clinical

  • Treatment Monitoring of Immunotherapy and Targeted Therapy Using 18F-FET PET in Patients with Melanoma and Lung Cancer Brain Metastases: Initial Experiences
  • Deep-Learning Generation of Synthetic Intermediate Projections Improves 177Lu SPECT Images Reconstructed with Sparsely Acquired Projections
  • Lymphocyte Infiltration Determines the Hypoxia-Dependent Response to Definitive Chemoradiation in Head-and-Neck Cancer: Results from a Prospective Imaging Trial
Show more Clinical

Similar Articles

Keywords

  • FAPI
  • Breast cancer
  • Colorectal cancer
  • lung cancer
  • PET/CT
SNMMI

© 2021 Journal of Nuclear Medicine

Powered by HighWire